SavedAdd your journal

Journals / Retina-Vitreus / 2015 / Cilt: 23 - Sayı: 0

Central Retinal Vein Occlusion

Retina Ven Kök Tıkanıklığı

Sibel KADAYIFÇILAR
Pages
81–88
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Cataract and increased intraocular pressure side effects of corticosteroids should be kept in mind

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Central retinal vein occlusion is a common vascular disease of the retina.
📊
Key Findings & Data:Macular edema secondary to retinal vein occlusions is a significant complication affecting the vision.
💡
Conclusion & Impact:Cataract and increased intraocular pressure side effects of corticosteroids should be kept in mind
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Central retinal vein occlusion is a common vascular disease of the retina. Its complications like ischemia, macular edema, neovascularization and neovascular glaucoma may result in visual loss. Laser photocoagulation is the main treatment for neovascularization. For macular edema recently new treatments became available. Macular edema secondary to retinal vein occlusions is a significant complication affecting the vision. With intravitreal antiVEGF agents and corticosteroids edema decreases and the vision increases. However these drugs have limited time of efficacy, they need to be repeated. Cataract and increased intraocular pressure side effects of corticosteroids should be kept in mind

Özet

Retina ven kök tıkanıklığı, retinanın sık görülen damar hastalıklarından biridir. İskemi, maküla ödemi, neovaskülarizasyon ve neovasküler glokom gibi komplikasyonları görme kaybı ile sonuçlanabilir. Neovaskülarizasyonda başlıca tedavi lazer fotokoagülasyon olup maküla ödemi için son yıllarda yeni tedaviler gündeme gelmiştir. İntravitreal anti-VEGF ajanlar ve kortikosteroidler ile ödem azalmakta ve görme keskinliği artmaktadır. Ancak ilaçların etkisi sürelidir, tekrarları gerekmektedir. Kortikosteroidlerin katarakt ve göz içi basıncı artışı yan etkileri akılda tutulmalıdır

🔖

Cite This Article

KADAYIFÇILAR, S. (2015). Central Retinal Vein Occlusion. Retina-Vitreus, Cilt: 23 - Sayı: 0, 81–88. https://ajindex.com/articles/307638

References (11)

  1. Rogers S et al. The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. Ophthalmology 2010;117:313-9.
  2. Hahn P, Mruthyunjaya P, Fekrat S. Central retinal vein occlusion. In: Ryan SJ: Retina Vol II Medical Retina (Schachat AP and Sadda SR, ed.s) Elsevier Saunders, London 2013;1039-49.
  3. Hayreh SS. Retinal vein occlusion, Indian J Ophthalmol 1994;42:109-32.
  4. Tsui I, Kaines A, Havunjian MA, et al. Ischemic index and neovasculari- zation in central retinal vein occlusion. Retina 2011;31:105-10.
  5. Lima VC, Yeung L, Castro LC, et al. Correlation between spectral do- main optical coherence tomography findings and visual outcomes in central retinal vein occlusion. Clin Ophthalmol 2011;5:299-30. The Central Vein Occlusion Study Group. Natural history and clini- cal management of central retinal vein occlusion. Arch Ophthalmol 1997;115:486-91. The Central Vein Occlusion Study Group. Evaluation of grid pat- tern photocoagulation for macular edema in central vein occlusion: The Central Vein Occlusion Study Group M report. Ophthalmology 1995;102:1425-33. Scott IU. Management of macular edema associated with retinal vein occlusion. Arch Ophthalmol 2012;130:1314-6.
  6. Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth fac- tor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994;331:1480-7.
  7. Jonas JB, Kreissig I, Degenring RF. Intravitreal triamcinolone aceto- nide as treatment of macular edema in central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2002;240:782-3.
  8. Ip MS, Scott IU, VanVeldhuisen PC, et al. A randomized trial compa- ring the efficacy and safety of intravitreal triamcinolone with obser- vation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5. Arch Ophthalmol 2009;127:1101-14.
  9. Haller JA, Bandello F, Belfort R.Jr., et al. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology 2010;117:1134-46.
  10. Haller JA, Bandello F, Belfort R.Jr., et al. Dexamethasone intravitre- al implant in patients with macular edema related to branch or cent- ral retinal vein occlusion twelve-month study results. Ophthalmology 2011;118:2453-60.
  11. Funk M, Kriechbaum K, Prager F, et al. Intraocular concentrations of growth factors